Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Ingenuity Ink Co-promotion Deal

NEW YORK (GenomeWeb News) – Ingenuity Systems and Affymetrix today announced a deal to co-promote each other's products.

Specifically, the terms of the deal call for the firms to co-promote Ingenuity iReport with Affy's expression microarray products. The combined products, Ingenuity and Affy said, will provide researchers a sample-to-insight continuous workflow "for rapid, confident interpretation of results without the need for bioinformatics experience or support."

Ingenuity iReport is an interactive, web-based report that uses the Ingenuity Knowledge Base of biological and chemical data culled from peer-reviewed literature and databases.

"Bundling together our robust expression microarrays with the iReport platform will provide Affymetrix's customers with a simple and accurate tool to convert data into biologically relevant results," Kevin Cannon, senior vice president of the expression business unit at Affy, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more